| Economic analysis of methamphetamine prevention effects and employer costs. | |
| | |
MedLine Citation:
|
PMID: 21683039 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The goal of this research was to evaluate economically three interventions designed to prevent substance use in general populations of adolescents, specifically focusing on the prevention of methamphetamine use and its subsequent benefits to employers. METHOD: In a randomized, controlled trial, three preventive interventions were delivered to 6th- or 7th-grade youth in 58 Iowa school districts, with 905 of these youth (449 girls) providing follow-up assessments as 12th graders. Intervention conditions included the family-focused Iowa Strengthening Families Program (ISFP), the school-based Life Skills Training (LST) program, and a combined condition of both the Strengthening Families Program: For Parents and Youth 10-14 (SFP10- 14; an ISFP revision) plus LST (LST + SFP10-14). Analyses based on intervention costs, 12th-grade methamphetamine use rates, and methamphetamine- related employer costs yielded estimates of intervention cost, cost-effectiveness, benefit-cost ratio, and net benefit. RESULTS: The ISFP lowered methamphetamine use by 3.9%, cost $25,385 to prevent each case, and had a benefit-cost ratio of 3.84, yielding a net benefit of $2,813 per youth. The LST program reduced methamphetamine use by 2.5%, required $5,122 per prevented case, and had a benefit-cost ratio of 19.04, netting $2,273 per youth. The combined LST + SFP10-14 prevention condition lowered methamphetamine use rates by 1.8%, cost $62,697 to prevent each case, had a benefit-cost ratio of 1.56, and netted $620 per youth. Findings were robust after varying a number of key parameters across a range of plausible values. CONCLUSIONS: Substance use prevention programming is economically feasible, particularly for effective interventions that have lower per person treatment delivery costs. |
| | |
Authors:
|
Max Guyll; Richard Spoth; D Max Crowley |
Related Documents
:
|
22081379 - Cost function analysis for solid waste management: a developing country experience. 9436069 - Peer-led asthma education for adolescents: impact evaluation. 16234399 - Surveillance for isocyanate asthma: a model based cost effectiveness analysis. 11948069 - Use of specific inhalation challenge in the evaluation of workers at risk for occupatio... 16882779 - Asthma prevalence in hispanic and asian american ethnic subgroups: results from the cal... 10662119 - System looks outside its own walls to find innovative way to cut kids' asthma admissions. 10173129 - Medicare program; adjustment in payment amounts for new technology intraocular lenses--... 19948049 - Using process evaluation for program improvement in dose, fidelity and reach: the act t... 22096449 - Predictive measures of a resident's performance on written orthopaedic board scores. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: Journal of studies on alcohol and drugs Volume: 72 ISSN: 1938-4114 ISO Abbreviation: J Stud Alcohol Drugs Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-06-20 Completed Date: 2012-01-20 Revised Date: 2012-05-02 |
Medline Journal Info:
|
Nlm Unique ID: 101295847 Medline TA: J Stud Alcohol Drugs Country: United States |
Other Details:
|
Languages: eng Pagination: 577-85 Citation Subset: IM |
Affiliation:
|
Department of Psychology, Iowa State University, Ames, 50011-3180, USA. guyll@iastate.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Central Nervous System Stimulants* / adverse effects Cost-Benefit Analysis Employer Health Costs / statistics & numerical data* Employment / economics* Female Humans Iowa Male Methamphetamine* / adverse effects Preventive Medicine / economics*, methods Schools Substance-Related Disorders / prevention & control* Universities / economics, statistics & numerical data |
| Grant Support | |
ID/Acronym/Agency:
|
2R01 DA010815-11/DA/NIDA NIH HHS; R01 AA14702/AA/NIAAA NIH HHS; R01 DA010815/DA/NIDA NIH HHS; R01 DA010815-13/DA/NIDA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Central Nervous System Stimulants; 537-46-2/Methamphetamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Drug and alcohol involvement in four types of fatal crashes.
Next Document: Risk of marijuana use in male and female college student athletes and nonathletes.